Service Plan for Illumina NovaSeq & MiSeq sequencers
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health (NIH) intends to procure a Fixed Priced One-Year Silver Support Plan for their Illumina NovaSeq 6000 and MiSeq DNA sequencers. This acquisition is being conducted on a sole source basis with Illumina Inc. due to the specialized nature of the equipment and services. Responses from other sources must include signed documentation confirming authorization and certified capability from Illumina. Quotations are due February 5, 2026, by 9:00 AM EDT.
Scope of Work
The requirement is for a Silver Support Plan covering the period from March 11, 2026, to March 10, 2027, for one NovaSeq 6000 and one MiSeq DNA Sequencer. The plan includes:
- Full coverage for repair parts, labor, and travel.
- Reagent/kit replacement upon hardware failures.
- One annual preventative maintenance (PM).
- Remote technical support (18x5) with a 24-business-hour acknowledgment and 2-business-day on-site response target.
- Control hardware/software updates, on-site applications support, and discounted advanced application training.
- Access to OEM certified replacement parts and loaner equipment (for active Illumina service contract holders).
- On-site Field Application Scientist Support and 5x18 phone support (M-F, 8:00 AM to 5:00 PM PST) with 5x24 email access.
Contract & Timeline
- Type: Combined Synopsis/Solicitation (RFQ), Fixed-Price, Sole Source.
- Solicitation Number: 75N94026Q00038.
- NAICS: 811210 (Maintenance, Repair And Rebuilding Of Equipment: Instruments And Laboratory Equipment), Size Standard $34M.
- Set-Aside: None (Not set aside for small business).
- Response Due: February 5, 2026, 9:00 AM EDT.
- Published: January 27, 2026.
- Place of Performance: Bethesda, MD 20892.
Justification for Sole Source
Illumina sequencers are critical for NICHD's DNA sequencing needs, providing high accuracy and throughput. The uniqueness and sophistication of these machines necessitate highly specialized care and maintenance. Illumina is the sole authorized provider of service, offering factory-trained representatives, proprietary software for remote monitoring, and exclusive access to OEM parts. Using third-party providers could lead to significant downtime, financial burdens, and reduced research productivity, jeopardizing critical experiments. This acquisition is authorized under 41 U.S.C. 253(c)(1) and FAR 6.302.
Submission Requirements
Offerors must provide signed documentation from Illumina Inc. confirming authorization and certified capability to provide all specified services and products. Responses lacking this OEM confirmation will be considered invalid. A completed copy of FAR Clause 52.212-1, Instructions to Offerors, must also be included. All offerors must be registered in SAM.gov.
Applicable Clauses
Key FAR clauses include 52.212-4 (Terms and Conditions), 52.204-7 (SAM Registration), and 52.222-48 (Exemption from Service Contract Labor Standards for Maintenance). A full list is available at acquisition.gov/far.